Mekanar Pharma

Hyderabad, India
Offers contract services for API development, manufacturing, and research globally.

About Mekanar Pharma

Mekanar Pharma is a Healthcare company based in Hyderabad (India). It offers contract services for API development, manufacturing, and research globally. It operates on a B2B model. The company has 10 employees. Its Indian entity Mekanar Pharma Private Limited reported revenue of β‚Ή3.20 Cr. Mekanar Pharma offers products and services including APIs, CDMO, CRO, and IPR. Its focus areas include Life Sciences, Pharmaceuticals, Contract Research and Drug Development Services.

Company details

Mekanar Pharma specializes in end-to-end services for the API industry, including contract research, development, and manufacturing of active pharmaceutical ingredients and intermediates. They focus on cost-effective, environmentally friendly processes to support global commercialization, partnering with clients for efficient drug development. Based in Hyderabad, India, they emphasize intellectual property creation and regulatory compliance.

Key Metrics
  • Annual Revenue
    ₹3.20 Cr

    FY 2025 · +50% YoY

  • Net Profit
    ₹2.2 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹13.8 Lakh

    FY 2025 · 4% margin

  • Employee Count
    10

Products & Services of Mekanar Pharma

Mekanar Pharma offers a comprehensive portfolio of products and services, including APIs, CDMO, CRO, and IPR.

APIs
Manufacturing

Development and production of active pharmaceutical ingredients for clients

CDMO
Contract Services

End-to-end contract development and manufacturing solutions

CRO
Research Services

Contract research for drug substances and processes

IPR
Intellectual Property

Services for patent filing and process innovation

Board of directors of Mekanar Pharma Private Limited (Mekanar Pharma)

Mekanar Pharma Private Limited is the primary company behind Mekanar Pharma. The board of Mekanar Pharma Private Limited currently have 3 directors; the longest-serving is Jwala Srinivasa Phani Krishna Darsi, appointed in 2022. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Jwala Srinivasa Phani Krishna Darsi
DIN 09633225
Whole-time director09 Jun 20224 yrs 4 moMekanar Pharma Private Limited
Kathyayini Pasthula
DIN 09633224
Whole-time director09 Jun 20224 yrs 4 moMekanar Pharma Private Limited
Srinivasa Rao Metta
DIN 09633223
Managing Director09 Jun 20224 yrs 4 moMekanar Pharma Private Limited

Financials of Mekanar Pharma

Figures of Mekanar Pharma Private Limited, the primary company behind Mekanar Pharma, for FY 2025. Revenue was ₹3.20 Cr (+50% year on year). Net profit was ₹2.2 Lakh (1% margin). EBITDA was ₹13.8 Lakh (4% margin).

  • ₹3.20 CrRevenue · FY 2025 · +50% YoY
  • ₹2.2 LakhNet profit · 1% margin
  • ₹13.8 LakhEBITDA · 4% margin
  • ₹27.5 LakhPaid-up capital
  • 10Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Mekanar Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Mekanar Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Mekanar Pharma

Mekanar Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Mekanar Pharma has 10 employees.

The primary company behind Mekanar Pharma, Mekanar Pharma Private Limited, reported revenue of β‚Ή3.20 Cr for FY 2025, up 50% year on year.

Mekanar Pharma specializes in end-to-end services for the API industry, including contract research, development, and manufacturing of active pharmaceutical ingredients and intermediates. They focus on cost-effective, environmentally friendly processes to support global commercialization, partnering with clients for efficient drug development. Based in Hyderabad, India, they emphasize intellectual property creation and regulatory compliance.

Mekanar Pharma offers APIs, CDMO, CRO, and IPR.

Mekanar Pharma operates through Mekanar Pharma Private Limited.

The legal entities of Mekanar Pharma currently have 3 directors, including Jwala Srinivasa Phani Krishna Darsi, Kathyayini Pasthula, Srinivasa Rao Metta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available